Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Healthcare Services (HCSG) Cash & Equivalents (2016 - 2025)

Historic Cash & Equivalents for Healthcare Services (HCSG) over the last 17 years, with Q4 2025 value amounting to $125.2 million.

  • Healthcare Services' Cash & Equivalents rose 12049.63% to $125.2 million in Q4 2025 from the same period last year, while for Dec 2025 it was $125.2 million, marking a year-over-year increase of 12049.63%. This contributed to the annual value of $125.2 million for FY2025, which is 12049.63% up from last year.
  • Healthcare Services' Cash & Equivalents amounted to $125.2 million in Q4 2025, which was up 12049.63% from $124.4 million recorded in Q3 2025.
  • Over the past 5 years, Healthcare Services' Cash & Equivalents peaked at $125.2 million during Q4 2025, and registered a low of $16.2 million during Q1 2023.
  • Over the past 5 years, Healthcare Services' median Cash & Equivalents value was $43.6 million (recorded in 2022), while the average stood at $58.8 million.
  • Per our database at Business Quant, Healthcare Services' Cash & Equivalents crashed by 7532.98% in 2022 and then surged by 35975.97% in 2025.
  • Over the past 5 years, Healthcare Services' Cash & Equivalents (Quarter) stood at $70.8 million in 2021, then plummeted by 62.88% to $26.3 million in 2022, then soared by 106.74% to $54.3 million in 2023, then rose by 4.5% to $56.8 million in 2024, then surged by 120.5% to $125.2 million in 2025.
  • Its last three reported values are $125.2 million in Q4 2025, $124.4 million for Q3 2025, and $82.8 million during Q2 2025.